CSIMarket
 
Carmell Corporation  (NASDAQ: CTCX)
Other Ticker:  
 
 
 

Carmell Corporation's vs. its Competitors Results

(List of Competitors, Financial Results 12 Months from the last period ending MRQ, in Millions of $)



COMPANY NAME TICKER REVENUE NET INCOME NET MARGIN CASH FLOW
Carmell Corporation 3 Q 2024 CTCX 0.00 -13.43 - -6.83
Natera Inc 3 Q 2024 NTRA 1,531.96 -214.69 -14.01 % 224.13
Vericel Corporation 2 Q 2024 VCEL 214.52 0.79 0.37 % 5.04
Mesoblast Ltd 2 Q 2024 MESO 5.90 -87.96 -1490.27 % 129.33
Capricor Therapeutics inc 3 Q 2024 CAPR 23.23 -27.49 -118.34 % -32.43
Vycor Medical Inc 3 Q 2024 VYCO 1.44 -0.13 -9.06 % 0.10
Arch Therapeutics Inc 2 Q 2024 ARTH 0.15 -12.26 -8276.53 % -0.72
Therapeutic Solutions International Inc 3 Q 2024 TSOI 0.03 -4.93 -17618.74 % -0.11
Endonovo Therapeutics Inc 3 Q 2023 ENDV 0.26 -4.40 -1722.23 % -0.02
Athersys Inc 3 Q 2023 ATHX 5.33 -83.37 -1565.65 % -12.76
Marizyme Inc 2 Q 2024 MARZ 0.55 -52.51 -9553.51 % -0.20
Harvard Apparatus Regenerative Technology Inc 3 Q 2024 BSTG 0.24 -4.96 -2110.64 % 1.66
APROX. MARKET 3 Q SUBTOTAL 1,783.59 -505.35 - 314.03




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com